The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
open-angle glaucoma and ocular hypertension
Alphagan has been approved for the treatment of open-angle
glaucoma and ocular hypertension.
Mechanism of Action
Alphagan is a selective alpha-2 agonist, which significantly
lowers intraocular pressure with minimal effects on cardiovascular
and pulmonary parameters. Its unique dual mechanism of action
lowers intraocular pressure by reducing aqueous humor production
and increasing uveoscleral outflow.
Glaucoma, an eye disease commonly characterized by excessive
intraocular pressure, is a leading cause of blindness in the